Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF).
Bregni
M
M
Department of Cancer Medicine, Istituto Nazionale Tumori, Milano, Italy.
Siena
S
S
Bonadonna
G
G
Gianni
A M
AM
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001804:Blood Transfusion, Autologous; D003131:Combined Modality Therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007958:Leukocyte Count; D009369:Neoplasms / Q000628:therapy; D010976:Platelet Count; D011994:Recombinant Proteins / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor